Centrifuge Integrates Symbiotic Liquidity, Expands $1.6B Janus/NYLIM

Centrifuge has expanded its tokenized-fund liquidity options by adding Symbiotic’s Liquid Lane to three of its offerings, enabling eligible holders to exchange fund positions for USDC. The upgrade is aimed at making redemptions more immediate for users, while the funds’ standard redemption process can occur separately.

The integration covers Janus Henderson’s JAAA, an AAA-rated collateralized loan obligation (CLO) strategy; Janus Henderson’s JTRSY, a short-duration US Treasury strategy; and New York Life Investment Management’s HYB, a US high-yield corporate bond strategy. Together, these funds represent about $1.6 billion in assets under management, according to the announcement.

Key takeaways

• Centrifuge added Symbiotic’s Liquid Lane to three tokenized funds to provide another path for eligible holders to receive USDC.


• Liquid Lane uses an onchain request-for-quote (RFQ) marketplace, allowing market makers to source liquidity from vaults to meet redemption demand.


• Investors can receive USDC immediately, while the underlying tokenized fund redemption can be processed separately through the issuer or via RFQ.


• Centrifuge already offered instant redemptions through partnerships such as Wintermute and other liquidity arrangements, and Liquid Lane focuses on the transaction capital structure.


• The project’s broader thesis is that aggregating redemption flow across issuers and asset classes could improve liquidity economics as tokenized assets see wider onchain use.

How Symbiotic’s Liquid Lane changes the redemption workflow

Symbiotic’s Liquid Lane is built around an onchain RFQ marketplace. When redemption requests are placed, market makers can access liquidity from Symbiotic vaults to fill those requests. After acquiring the fund tokens through the RFQ interaction, market makers may then redeem the tokens with the issuer or transfer/sell them via another RFQ transaction.

This design matters because it decouples the user’s immediate liquidity outcome from the slower mechanics of traditional redemption cycles. In the Centrifuge setup described, eligible investors are able to receive USDC right away while the funds’ normal redemption process proceeds on its own schedule.

Symbiotic did not position Liquid Lane as the only redemption route; instead, it’s presented as an additional liquidity pathway designed to increase participation and improve execution for tokenized-fund holders.

Why Centrifuge and these specific funds

Centrifuge is an asset tokenization and vault platform where asset managers issue and manage tokenized funds. The three products now integrated with Liquid Lane represent a meaningful slice of Centrifuge’s institutional coverage, spanning structured credit, short-duration Treasuries, and high-yield corporate exposure.

Janus Henderson has been a significant contributor to Centrifuge’s growth, particularly through its JAAA and JTRSY products—an expansion that earlier coverage tied to Centrifuge’s progress in attracting institutional demand, including milestones reported by Cointelegraph (see Centrifuge surpasses $1B TVL in institutional demand).

By December 2025, Token Terminal estimated Centrifuge had attracted around $1.3 billion in new inflows, driven primarily by Janus Henderson’s two funds. Token Terminal also reported that JAAA alone accounted for roughly $1 billion in total value locked and was among the largest tokenized funds in the market.

Liquid Lane alongside existing instant-liquidity routes

Liquid Lane is not the first liquidity solution connected to Centrifuge’s tokenized funds. Felix Lutsch, head of Symbiotic ecosystem, told Cointelegraph that the network is not attempting to replace earlier approaches, emphasizing instead that multiple liquidity routes can coexist.

According to Centrifuge’s own disclosures, a partnership with Wintermute announced in February 2025 supported 24/7 instant redemptions for JTRSY. Separately, HYB launched in June under a different arrangement targeting near-instant redemptions.

Lutsch said the differentiation of Liquid Lane is not primarily about speed, but about the capital structure used to execute redemption demand. In his description, Liquid Lane’s RFQ marketplace can involve multiple market makers and curators without requiring every market maker to pre-fund and carry inventory for specific assets.

That distinction connects to a broader market constraint Lutsch highlighted: while tokenized asset markets can offer settlement benefits, historical low trading volumes have reduced market makers’ incentives to commit capital. He argued that routing and aggregating redemption demand across issuers and asset classes could improve liquidity economics as tokenized funds increasingly function as collateral and financing assets in onchain markets.

From an investor perspective, the practical implication is that users may have more execution options as liquidity providers face less inventory burden and can scale their participation across assets—potentially reducing friction when demand for redemptions rises.

What to watch next

As Centrifuge extends Symbiotic’s Liquid Lane to more fund products and as tokenized-fund liquidity competes across multiple RFQ and instant-redemption mechanisms, investors should watch whether trading and redemption volumes grow enough to attract and sustain market-maker participation—since Liquid Lane’s thesis depends on improving flow-driven liquidity economics.

https://www.cryptobreaking.com/centrifuge-integrates-symbiotic-liquidity-expands/?utm_source=blogger%20&utm_medium=social_auto&utm_campaign=Centrifuge%20Integrates%20Symbiotic%20Liquidity,%20Expands%20$1.6B%20Janus/NYLIM%20